Careers | Events | Media | info@cramsn.com | +91 845 230 4710 |

Empowering Innovation with
State-of-the-Art Infrastructure

CRAMSN Research Park offers cutting-edge infrastructure and comprehensive capabilities to meet client needs from discovery through commercialization. Our facilities include 2 state-of-the-art R&D centers and have access to 17 API manufacturing units, and 8 fully-integrated FDF facilities.

CRAMSN Research Park

With extensive infrastructure dedicated to innovation and development, CRAMSN operates a comprehensive R&D facility that spans 1,84,000 sq. ft. Our manufacturing facilities are regularly audited by major international regulatory bodies to ensure compliance and quality at every level.

Specialized Laboratories:

Our R&D center hosts dedicated labs tailored for diverse specialties, including:

  • High-potency active pharmaceutical ingredients (HPAPIs).
  • Prostaglandins, labeled compounds, and iron complexes.
  • Flow chemistry, peptides, oligonucleotides.
  • Particle size engineering.
Specialized Laboratories

Advanced Synthetic Capabilities:

40 synthetic labs equipped with approximately 350 fume hoods for optimized safety and functionality.

Specialized engineering labs focusing on process safety studies and process intensification to enhance operational efficiency.

Advanced Synthetic Capabilities

Scale-Up Facilities:

A dedicated scale-up area with reactor capacities from 10L to 100L under CGMP standards.

Clean room facilities designed to produce materials for Phase I, II, and III clinical trials, ensuring stringent compliance with clinical development needs.

Scale-Up Facilities

Analytical Center

Our 45,000 sq. ft analytical center is fully equipped to support a variety of analytical and quality assurance processes essential for reliable product development and manufacturing.

Key Features

  • Ultra-modern instruments that provide comprehensive analytical capabilities.
  • Support for laboratory development as well as method transfers, validations, and scale-up processes.
  • Facilities for solid-state and structural characterization to ensure product stability and efficacy.

Services Offered

  • Method development and validations
  • Purification support for complex projects.

Manufacturing Infrastructure

CRAMSN’s manufacturing infrastructure is built to support production at every scale, from grams to tons, while upholding the highest standards of quality and compliance. Our advanced drug substance and drug product facilities are equipped to fulfill a diverse range of client requirements.

Drug Substance Manufacturing :

Our API manufacturing capabilities include a robust setup for producing a diverse array of drug substances:

  • 17 manufacturing facilities equipped with over 2,400 reactors, offering a combined reaction volume of 10,000 KL.
  • Reactor range: Capacities from 20L to 20KL for tailored production scalability.
  • HPAPI (High-Potency Active Pharmaceutical Ingredients) facilities: Two specialized units designed to handle high-potency compounds across all safety bandwidths (up to 0.01 µg/m³ exposure levels).

Cryogenic Rector

12 KL

Operating Range -90 oC to 140 oC

HPAPI Facility

< 0.1 µg/m3

Hydrogenation Facility

6 KL

Pressure Range 5 - 10Kg/cm 2

Spray Dryer

(Onco & non-Onco Facility)

10 kg/batch

maximum capacity

Particle Size Reduction

(Onco & non-Onco facility in class 100,000 area)

< 10

micron with nitrogen and air

Drug Product Infrastructure

Drug Product
Infrastructure

CRAMSN’s extensive FDF manufacturing capabilities allow for high-volume production across a wide variety of drug forms.

FDF Production Capacities :

Tablets

~15 billion
annually

Sachets

~120 million
annually

Oral Suspensions

~8.0 million
annually

Capsules

~4.0 million
annually

Parenterals (Lyophilized & Liquid)

~40 million
annually.

Capsules

~3k tons
annually

+91 845 230 4710 info@cramsn.com Plot No: 5, Phase:4, Pashamylaram, Patancheru Mandal, Sangareddy District, Hyderabad, Telangana, 502307

Copyrights © , All Rights Reserved by CRAMSN.

Search